Top Life Sciences Startups in 2026

We are an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted partners delivering smart, fast and flexible testing solutions supported by reliable, cost-effective screening products and best-in-class technology. ​ ​

Basetwo provides a no code AI platform that helps manufacturing engineers troubleshoot and optimize their production processes to increase efficiency and reduce waste. Manufacturing engineers can use the Basetwo platform to rapidly ingest, merge and transform large datasets in order to build actionable digital twins of their plant. Using Basetwo's library of digital twins, engineers can improve their understanding of their plant performance, and run real-time scenario analyses to improve yield, product quality and efficiency of their plant.

Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click’s treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. Click Therapeutics continuously expands and refines its platform with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such as artificial intelligence and machine learning. The digital therapeutics under development on Click’s platform address diverse areas of therapeutic need, including indications in psychiatry, neurology, oncology, immunology, and cardiometabolic diseases. Consistently named a best place to work, Click fosters an inclusive, diverse workforce of innovators, clinicians, scientists, researchers, designers, technologists, engineers and more, united in a common mission to provide patients everywhere access to safe and effective prescription digital therapeutics. For more information, visit clicktherapeutics.com and connect with us on LinkedIn.

Evvy is taking the guesswork out of female health by building new datasets to close the gender health gap. We’re starting with the vaginal microbiome, which plays a critical role in outcomes — from vaginal infections to preterm birth to gynecological cancers. Our easy to use, at-home test finally gives women access to this information on our bodies, enabling us to take control of our preventative health. Simultaneously, we're unlocking groundbreaking insights on how these biomarkers can be leveraged to detect and treat a variety of critical health conditions in the female body. Backed by General Catalyst and featured in Inc and TechCrunch, Evvy is employing world class technology to close critical gaps in the experiences, datasets, and products in women’s health. If you’re excited about our mission, we’d love to chat!

Products, technologies, and services for less-invasive medical specialties.

Clear Labs offers next-generation sequencing and data analytics for infectious disease surveillance and food safety testing. The company's platforms, Clear Dx™ and Clear Safety™, enable rapid identification of pathogens and support public health initiatives. The company focuses on delivering actionable insights to enhance safety and operational efficiency in various sectors.

Mammoth biosciences is harnessing the diversity of nature to power the next generation of crispr products. through its discovery of novel crispr systems, the company is enabling the full potential of its platform to read and write the code of life. with a distinguished team including co-founder and crispr-cas gene editing co-inventor jennifer doudna, mammoth is addressing challenges across healthcare, agriculture, environmental monitoring, biodefense, and more.

Savara is an inhalation drug development company. Our lead product addresses an unmet clinical need in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in patients with cystic fibrosis (CF) and in other high risk patient populations. MRSA is a growing problem, with a 6 year reduction in life expectancy for infected CF patients and no suitable treatment. The product is in preparation for its first human clinical trial.

We help solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.